Consensus DexCom, Inc. Xetra

Stocks

DC4

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Xetra 09:05:36 02/10/2026 pm IST			5-day change	1st Jan Change
76.40 ^EUR	-0.52%		-0.26%	+33.19%

01/10	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT
28/09	Dexcom Publishes New Report During Easd 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care	CI

8e93b8aff068ff718e433c7b25957b54.3wD0zrQekHsU73_KYz9oUHBg2wc4UDmBil8f--Rg6qk.nm6-m9ByqBFWpzmrLV0_GDMht3dfAgqx_R10lskqneqtZa2h5X30QmTYOg~60b0b7aca30002be0abf5c51f449a7df

Analysts' recommendations: DexCom, Inc.

01/10	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT
17/09	Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating	MT
13/08	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT
04/08	Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating	MT
03/08	UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating	MT
03/08	Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating	MT
31/07	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says	MT
31/07	Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating	MT
31/07	RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating	MT
31/07	Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating	MT
31/07	Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating	MT
31/07	Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating	MT
31/07	Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating	MT
31/07	Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating	MT
31/07	Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating	MT
31/07	Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating	MT
31/07	Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating	MT
31/07	JPMorgan Adjusts Price Target on DexCom to $82 From $65, Maintains Neutral Rating	MT
31/07	Piper Sandler Adjusts Price Target on DexCom to $95 From $88, Maintains Overweight Rating	MT
31/07	Wells Fargo Adjusts Price Target on DexCom to $90 From $85, Maintains Overweight Rating	MT
31/07	Stifel Adjusts Price Target on DexCom to $95 From $90, Maintains Buy Rating	MT
31/07	Citigroup Adjusts Price Target on DexCom to $88 From $84, Maintains Buy Rating	MT
31/07	Jefferies Adjusts Price Target on DexCom to $115 From $112, Maintains Buy Rating	MT
31/07	BTIG Adjusts Price Target on DexCom to $90 From $80, Maintains Buy Rating	MT
31/07	Raymond James Adjusts Price Target on DexCom to $94 From $91, Maintains Strong Buy Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+23.68%
	MEDTRONIC PLC					+21.36%
	STRYKER CORPORATION					+33.54%
	ESSILORLUXOTTICA					+62.89%
	CENCORA, INC.					+19.48%
	HOYA CORPORATION					+24.9%
	BECTON, DICKINSON AND COMPANY					+10.67%
	IDEXX LABORATORIES, INC.					+35.29%
	DEXCOM, INC.					+11.39%
	Average					+27.02%
	Weighted average by Cap.					+27.95%